Physician profile
Sari Williams
NPI 1295272201
$1,085.18
in general payments reported to CMS, 2019-2025
10 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $455 · 2023: $239 · 2024: $267 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $630.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $278.31 | 2022 | |
| Medtronic, INC. | $214.58 | 2024 | Synchromedii |
| Collegium Pharmaceutical, INC. | $172.59 | 2022-2023 | Belbuca |
| Vertex Pharmaceuticals Incorporated | $124.50 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $116.29 | 2022-2023 | Relistor |
| Averitas Pharma INC. | $70.00 | 2023 | Qutenza |
| Merck Sharp & Dohme LLC | $38.27 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $36.72 | 2024 | Libtayo |
| Seagen INC. | $17.81 | 2023 | Adcetris |
| Daiichi Sankyo INC. | $16.11 | 2024 | Vanflyta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sari Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.